Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Anemia, Aplastic (Phase 1/Phase 2)
Anemia, Diamond-Blackfan (Phase 1/Phase 2)
Anemia, Sickle Cell (Phase 1/Phase 2)
beta-Thalassemia (Phase 2)
Common Variable Immunodeficiency (Phase 2)
Deficiency Diseases (Phase 2)
Granuloma (Phase 2)
Hematologic Neoplasms (Phase 1/Phase 2)
Idiopathic Pulmonary Fibrosis (Phase 1/Phase 2)
Job Syndrome (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Lupus Erythematosus, Systemic (Phase 2)
Mycobacterium (Phase 2)
Neoplasms (Phase 1)
Neutropenia (Phase 2)
Pelvic Inflammatory Disease (Phase 2)
Primary Immunodeficiency Diseases (Phase 2)
Pulmonary Disease, Chronic Obstructive (Phase 2)
Scleroderma, Systemic (Phase 2)
Wiskott-Aldrich Syndrome (Phase 1/Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue